(Q41739095)

8 October 2017

1 reference

title

Pentatomic cyclic antagonists and muscarinic receptors: a 30-year review (English)

1 reference

8 October 2017

Angeli P

1

1 reference

8 October 2017

publication date

1 January 1998

1 reference

8 October 2017

1 reference

8 October 2017

volume

53

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

1-21

1 reference

Pirenzepine distinguishes between different subclasses of muscarinic receptors

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Structure-activity relations for anticholinergic dioxolans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

A comparison of the stereochemical requirements of cholinergic and anticholinergic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Structure-activity relations for anticholinergic 2(1-aryl(or cyclohexyl)-1-hydroxy-1-phenyl)methyl-1,3-dioxolans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Structural parameters determining cholinergic and anticholinergic activities in a series of 1,3-dioxolanes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

A new probe for heterogeneity in muscarinic receptors: 2-methyl-spiro-(1, 3-dioxolane-4, 3')-quinuclidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Synthesis, NMR spectroscopy study, and antimuscarinic activity of a series of 2-(Acyloxymethyl)-1,3-dioxolanes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic head.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane 3-oxide methiodides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Eudismic analysis of a series of muscarinic ligands carrying a 1,3-oxathiolane nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Molecular modification of anticholinergics as probes for muscarinic receptors. 3. Conformationally restricted analogues of benactyzine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Synthesis and antimuscarinic properties of some N-substituted 5-(aminomethyl)-3,3-diphenyl-2(3H)-furanones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Synthesis and antimuscarinic activity of some 1-cycloalkyl-1-hydroxy-1-phenyl-3-(4-substituted piperazinyl)-2-propanones and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Stereoselectivity of procyclidine binding to muscarinic receptor subtypes M1, M2 and M4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Muscarinic receptor binding profile of para-substituted caramiphen analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Caramiphen, iodocaramiphen and nitrocaramiphen are potent, competitive, muscarinic M1 receptor-selective agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Cholinergic agents structurally related to furtrethonium. 2. Synthesis and antimuscarinic activity of a series of N-[5-[(1'-substituted-acetoxy) methyl]-2-furfuryl]dialkylamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Dialkylaminoalkyl esters of 2,2-diphenyl-2-alkylthioacetic acids: a new class of potent and functionally selective muscarinic antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Cardioselective derivatives of 2,2-diphenyl-2-ethylthioacetate do not discriminate between m2 and m3 muscarinic receptors expressed in CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Stereoselective interaction of uncharged esters at four muscarinic receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Molecular biology of muscarinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Effects of chain-length and unsaturation on affinity and selectivity at muscarinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Quantitative correlations and reexamination of the importance of hydrophobic and steric factors in anticholinergic drug receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Relationship of three-dimensional structure of muscarinic antagonists to antimuscarinic activity: structure of thiodeacylaprophen hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Theoretical quantitative structure-activity analysis of quinuclidine-based muscarinic cholinergic receptor ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Theoretical quantitative structure—activity relationship analysis on three dimensional models of ligand—m1 muscarinic receptor complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Molecular dynamics simulations of m3-muscarinic receptor activation and QSAR analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2897%2900005-0

10.1016/S0014-827X(97)00005-0

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference